VOBYXA
Live / Applied — New application — assigned to an examiner (as of 27 Mar 2026)
What this means for you
Not registered yet, but its 09 Dec 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79443071
- Mark type
- Stylized text
- Filed
- 09 Dec 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- NOVARTIS AG, CH
Prosecution history
- 27 Mar 2026 — ASSIGNED TO EXAMINER
- 25 Mar 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 25 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 09 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 09 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Mar 2026 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 05 Feb 2026 — SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB